Table 1.
Averaged area under the ROC curve (AUC) and coefficient of determination (R 2probit), as well standard deviations (between parenthesis), obtained from the testing sets in the 10 fold-crossvalidation analyses of time to first recurrence (TFR) and time to progression in the whole (TP), high risk (TPHiR) and low risk (TPLR) cohorts
| Model | Criterion | TFR | TP | TPHiR | TPLR |
|---|---|---|---|---|---|
| Whole series | Whole series | HiR tumors | LR tumors | ||
| CPP | AUC | 0.62 (0.05) | 0.76 (0.09) | 0.57 (0.04) | 0.45 (0.02) |
| R 2probit | 0.031 (0.004) | 0.054 (0.013) | 0.151 (0.013) | 0.0358 (0.0094) | |
| SNPs | AUC | 0.55 (0.02) | 0.58 (0.09) | 0.56 (0.01) | 0.55 (0.01) |
| R 2probit | 0.010 (0.001) | 0.001 (0.000) | 0.009 (0.002) | 0.0005 (0.0002) | |
| CPP&SNPs | AUC | 0.61 (0.05) | 0.76 (0.10) | 0.57 (0.03) | 0.47 (0.02) |
| R 2probit | 0.041 (0.006) | 0.050 (0.013) | 0.155 (0.019) | 0.0267 (0.0099) |
CPP clinico-pathological prognosticators